NCT05631145View on ClinicalTrials.gov

MT Combined With XKSA for Depressive Symptoms During COVID-19

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

May 3, 2020

Primary Completion Date

October 1, 2020

Study Completion Date

October 15, 2020

Conditions
Depression, Anxiety
Interventions
OTHER

MT Combined With XKSA

Morita therapy (MT) comprised bed rest and light work. Xingnao Kaiqiao self-administered acupressure (XKSA) stimulates nine acupoints including Baihui, Sishenchong, Shenmen, Neiguan, Hegu, Taichong, Jianjing, Shenshu, and Yuji.

OTHER

MT

Morita therapy (MT) comprised bed rest and light work.

Trial Locations (1)

Unknown

Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen

All Listed Sponsors
lead

Renrong Wu

OTHER

NCT05631145 - MT Combined With XKSA for Depressive Symptoms During COVID-19 | Biotech Hunter | Biotech Hunter